Clincosm LogoSign in Get a demo

leukemia

Showing NaN - NaN of 108
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Leukemia Trial in United States (mercaptopurine, methotrexate, tretinoin)

Completed
Has Results
  • Leukemia
  • Scottsdale, Arizona
  • +209 more
Dec 14, 2022

Chronic Myelomonocytic Leukemia, Leukemia Trial in United States (Ruxolitinib)

Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • Leukemia
  • Tampa, Florida
  • +4 more
Nov 11, 2022

Validation for Early Cancer Detection and Minimal Residual

Recruiting
  • Brain Cancer
  • +19 more
    • Duarte, California
    • +6 more
    Nov 10, 2022

    Leukemia Trial in Canada, Puerto Rico, United States (Ruxolitinib, Asparaginase Erwinia Chrysanthemi, Cyclophosphamide)

    Recruiting
    • Leukemia
    • Birmingham, Alabama
    • +109 more
    Aug 11, 2022

    Collecting and Storing Tissue From Young Patients With Cancer

    Recruiting
    • Acute Lymphoblastic Leukemia
    • +13 more
    • Cytology Specimen Collection Procedure
    • Laboratory Biomarker Analysis
    • Birmingham, Alabama
    • +68 more
    Aug 4, 2022

    Hematopoietic and Lymphoid System Tumor, Leukemia, Lymphoma Trial in Canada, United States (procedure, biological, other)

    Active, not recruiting
    • Hematopoietic and Lymphoid System Neoplasm
    • +3 more
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +3 more
    • Birmingham, Alabama
    • +42 more
    Jul 20, 2022

    Leukemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide (ibrutinib, venetoclax, Placebo)

    Active, not recruiting
    Has Results
    • Leukemia
    • +2 more
    • Duarte, California
    • +45 more
    Jan 27, 2022

    Leukemia Trial in United States (cytarabine, idarubicin, pravastatin sodium)

    Active, not recruiting
    Has Results
    • Leukemia
    • Birmingham, Alabama
    • +184 more
    Feb 4, 2022

    Leukemia Trial in Cleveland (Melphalan, Thiotepa, Fludarabine)

    Recruiting
    • Leukemia
    • Cleveland, Ohio
      University Hospitals Seidman Cancer Center, Case Comprehensive C
    Jan 24, 2022

    Leukemia Trial in Worldwide (BMS-936564, Cytarabine)

    Terminated
    Has Results
    • Leukemia
    • Los Angeles, California
    • +37 more
    Aug 18, 2021

    Leukemia, Lymphoma Trial in United States (biological, drug, procedure)

    Active, not recruiting
    Has Results
    • Leukemia
    • Lymphoma
    • rituximab
    • +7 more
    • Duarte, California
    • +24 more
    Aug 16, 2021

    Leukemia Trial in Worldwide (asparaginase, cytarabine, daunorubicin HCl)

    Completed
    Has Results
    • Leukemia
    • Birmingham, Alabama
    • +197 more
    Mar 22, 2021

    Leukemia Trial in United States (rituximab, cyclophosphamide, pentostatin)

    Completed
    Has Results
    • Leukemia
    • rituximab
    • +3 more
    • Scottsdale, Arizona
    • +142 more
    Nov 9, 2020

    Chronic Myeloproliferative Disorders, Leukemia, MDS Trial in Cleveland (ascorbic acid, arsenic trioxide, dexamethasone)

    Completed
    • Chronic Myeloproliferative Disorders
    • +3 more
    • ascorbic acid
    • +3 more
    • Cleveland, Ohio
    • +1 more
    Jul 23, 2020

    Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Detroit, Cleveland, Philadelphia (educational

    Completed
    • Brain and Central Nervous System Tumors
    • +8 more
    • educational intervention
    • Detroit, Michigan
    • +3 more
    Jul 23, 2020

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)

    Completed
    • Chronic Myeloproliferative Disorders
    • +5 more
    • anti-thymocyte globulin
    • +5 more
    • Cleveland, Ohio
      Case Medical Center, University Hospitals Seidman Cancer Center,
    Jul 23, 2020

    Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Cleveland (biological, drug, procedure)

    Completed
    • Chronic Myeloproliferative Disorders
    • +5 more
    • anti-thymocyte globulin
    • +7 more
    • Cleveland, Ohio
      Ireland Cancer Center at University Hospitals Case Medical Cente
    Jul 23, 2020

    Leukemia Trial in United States (Azacitidine (AZA) Days 1 - 3, Decitabine (DAC), Best Supportive Care (BSC))

    Active, not recruiting
    • Leukemia
    • Azacitidine (AZA) Days 1 - 3
    • +3 more
    • Tampa, Florida
    • +5 more
    Jul 21, 2020

    Hematological Tumors, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma Trial in United States (CC-486, Vidaza)

    Completed
    • Hematological Neoplasms
    • +19 more
    • Scottsdale, Arizona
    • +9 more
    May 11, 2020

    Leukemia Trial in Canada, United States (rituximab, fludarabine phosphate)

    Terminated
    Has Results
    • Leukemia
    • rituximab
    • fludarabine phosphate
    • Anniston, Alabama
    • +386 more
    Apr 9, 2020

    Leukemia Trial in Canada, United States (biological, drug, other, procedure)

    Completed
    Has Results
    • Leukemia
    • anti-thymocyte globulin
    • +10 more
    • Birmingham, Alabama
    • +51 more
    Apr 7, 2020

    Leukemia Trial in Buffalo, Durham, Cleveland (drug, genetic, other, procedure)

    Completed
    Has Results
    • Leukemia
    • imatinib mesylate
    • +5 more
    • Buffalo, New York
    • +3 more
    Mar 4, 2020

    Leukemia, MDS Trial in Los Angeles, Tampa, Cleveland (azacitidine, lenalidomide)

    Completed
    Has Results
    • Leukemia
    • Myelodysplastic Syndromes
    • Los Angeles, California
    • +2 more
    Sep 18, 2018

    Leukemia Trial in Durham, Cleveland (Gemcitabine Hydrochloride, Mitoxantrone Hydrochloride)

    Terminated
    Has Results
    • Leukemia
    • Gemcitabine Hydrochloride
    • Mitoxantrone Hydrochloride
    • Durham, North Carolina
    • +1 more
    Jan 24, 2018

    Caregiver Support in Coping of UndergoingDonor Bone Marrow

    Completed
    • Chronic Myeloproliferative Disorders
    • +6 more
    • psychosocial assessment and care
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 25, 2018